Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RETIFANLIMAB Cause Haemoglobin decreased? 7 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Haemoglobin decreased have been filed in association with RETIFANLIMAB (ZYNYZ). This represents 7.3% of all adverse event reports for RETIFANLIMAB.

7
Reports of Haemoglobin decreased with RETIFANLIMAB
7.3%
of all RETIFANLIMAB reports
0
Deaths
7
Hospitalizations

How Dangerous Is Haemoglobin decreased From RETIFANLIMAB?

Of the 7 reports, 7 (100.0%) required hospitalization, and 7 (100.0%) were considered life-threatening.

Is Haemoglobin decreased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RETIFANLIMAB. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does RETIFANLIMAB Cause?

Diarrhoea (23) Nausea (14) Neutrophil count decreased (12) White blood cell count decreased (12) Disease progression (11) Neutropenic sepsis (11) Condition aggravated (9) Pulmonary embolism (9) Pyrexia (9) Asthenia (8)

What Other Drugs Cause Haemoglobin decreased?

LENALIDOMIDE (4,031) RUXOLITINIB (3,297) ECULIZUMAB (3,028) ADALIMUMAB (2,459) CLOZAPINE (2,396) RITUXIMAB (1,803) APIXABAN (1,779) NIRAPARIB (1,759) METHOTREXATE (1,754) RIBAVIRIN (1,753)

Related Pages

RETIFANLIMAB Full Profile All Haemoglobin decreased Reports All Drugs Causing Haemoglobin decreased RETIFANLIMAB Demographics